However, we keep the safety of these medicines under close review, including emerging evidence from scientific publications, and will take appropriate action where necessary
Tirzepatide stands out among GLP-1 receptor agonists due to its dual action on both GIP and GLP-1 receptors, enhancing weight loss and blood sugar control compared to those that target only GLP-1
Journal of Clinical Investigation, 91 (1), 301-307
Choi HY, Kim SW, Kim B, Lee HN, Kim SJ, Song M, Kim S, Kim J, Kim YB, Kim JH, Cho SG
Calculate your syringe units for 0.25 mg using the conversion chart above (or use the semaglutide dosage calculator )
Hair growth evidence is more indirect, with mouse and hair-follicle model studies rather than large clinical trials for hair loss [6], [13]